Evidence map›Paper›PMID 10947969›Full record

ArticleThe Biochemical journal2000

Identification of copper ligands in Aspergillus oryzae tyrosinase by site-directed mutagenesis.

M Nakamura, T Nakajima, Y Ohba, S Yamauchi, B R Lee, E Ichishima

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Maximizing dopa-oxidase activity in Aspergillus oryzae mycelia: insights into production optimization and potential biomedical applications.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  3. Article
  4. Sources and Applications of Tyrosinase in Life Sciences.Current pharmaceutical biotechnology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Biochemical Properties of Tyrosinase fromMolecules (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
  11. Structure-function correlations in tyrosinases.Protein science : a publication of the Protein Society · 2015
    Review
  12. Article
  13. Review
  14. Activation mechanism of melB tyrosinase from Aspergillus oryzae by acidic treatment.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2013
    Article
  15. Comparative genomics of trace element dependence in biology.The Journal of biological chemistry · 2011
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

M NakamuraLaboratory of Molecular Enzymology, Department of Molecular and Cellular Biology, Division of Life Science, Graduate School of Agricultural Science, Tohoku University, Japan. Tsutsumidori-Amamiyamachi, Aoba-ku, Sendai 981.
T Nakajima
Y Ohba
S Yamauchi
B R Lee
E Ichishima
Tohoku University · JPSoka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper ligands of the recombinant tyrosinase from the fungus Aspergillus oryzae expressed in Saccharomyces cerevisiae or Escherichia coli were identified by site-directed mutagenesis. The recombinant protyrosinases expressed in S. cerevisiae were assayed for catalytic activities of mono-oxygenase and L-dopa oxidase at pH 5.5 after acid shock at pH 3.0. Replacements of His-63, His-84, His-93, His-290, His-294, His-332 or His-333 with asparagine resulted in mutant enzymes exhibiting no activities. The site-directed mutant Cys82Ala showed that Cys-82 was also an essential residue for the activity. We obtained homogeneous preparations of activated tyrosinases from mutated thioredoxin fusion gene products expressed in E. coli by acid shock. The copper contents of engineered mutants and wild-type enzyme expressed in E. coli were determined by atomic absorption spectrophotometry. The wild-type enzyme contained 2 g-atoms of copper/mol of the subunit. The His63Asn, His84Asn, His93Asn, His290Asn, His294Asn, His332Asn, His333Asn or Cys82Ala substitution decreased copper binding by approx. 50%, indicating that the mutants contain only approx. 1 g-atom of copper/mol of the subunit. The five mutants His63Asn, His93Asn, His290Asn, His294Asn and Cys82Ala contain only one copper ion, which is fully detectable by EPR. From the correlation of g( parallel) and (Cu)A( parallel), we deduced that the nitrogen or sulphur donors in the copper ligands should be in a square or a distorted tetrahedral geometric environment. In further atomic absorption spectrophotometry experiments, no copper atom was observed in the seven double mutants His63Asn/His290Asn, His63Asn/His294Asn, His63Asn/His332Asn, His63Asn/His333Asn, Cys82Ala/His290Asn, His84Asn/His333Asn and His93Asn/His290Asn. We propose a new structure of active sites of tyrosinase from A. oryzae: the most likely binding sites of tyrosinase for Cu(A) are His-63, His-84 and His-93, with the remaining conserved Cys-82 providing the fourth ligand. Cu(B) liganded by four histidine residues, His-290, His-294, His-332 and His-333, is identified as new binding motif of Cu(B).

Indexed as

AlanineAmino Acid SequenceAsparagineAspergillus oryzaeBinding SitesBlotting, WesternCatalysisCircular DichroismCopperCysteineElectron Spin Resonance SpectroscopyElectrophoresis, Polyacrylamide GelEscherichia coliHistidineHydrogen-Ion ConcentrationLigandsAlanineAsparagineCopperCysteineHistidineL-dopa peroxidaseLigandsMonophenol MonooxygenaseNitrogenOxygenasesPeroxidasesRecombinant Fusion ProteinsRecombinant ProteinsSulfurThioredoxins

Identifiers

PMID10947969
PMCPMC1221282
OpenAlexW2138651210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.